Find Clarity for Unexplained Neurological Symptoms
When muscle jerks, seizures, or progressive movement difficulties disrupt your life, the uncertainty can be overwhelming. Our KCTD7 Progressive Myoclonus Epilepsy Type 3 genetic test provides the definitive answers you deserve, helping you understand the genetic basis of your symptoms and paving the way for targeted management strategies.
Understanding Your KCTD7 Genetic Test
This advanced Next-Generation Sequencing (NGS) test specifically examines the KCTD7 gene for mutations that cause Progressive Myoclonus Epilepsy Type 3. Unlike standard epilepsy tests, our analysis provides comprehensive genetic insights, identifying even rare variants that might be missed by conventional methods. The test requires only a simple blood sample or DNA extraction, making the process comfortable and straightforward.
Who Should Consider This Genetic Test?
This test is particularly important if you or your family members experience:
- Unexplained muscle jerks or myoclonus that worsens over time
- Progressive epilepsy that doesn’t respond well to standard treatments
- Neurological symptoms that began in childhood or adolescence
- Family history of similar movement disorders or epilepsy
- Declining cognitive function alongside movement symptoms
- Uncertain diagnosis despite multiple medical consultations
Why Early Detection Matters for Your Health
Identifying KCTD7 gene mutations early provides significant advantages:
- Personalised Treatment: Enables targeted medication and therapy approaches
- Family Planning: Provides crucial information for genetic counselling
- Symptom Management: Helps anticipate and prepare for disease progression
- Reduced Anxiety: Eliminates diagnostic uncertainty and multiple doctor visits
- Better Outcomes: Early intervention can improve quality of life significantly
Understanding Your Test Results
Our genetic counsellors provide clear, compassionate explanations of your results. You’ll receive:
- A detailed report explaining any identified KCTD7 gene mutations
- Information about what the results mean for your health management
- Guidance on next steps and available treatment options
- Support for discussing results with family members if needed
- Access to our network of neurological specialists across South Africa
Remember: A positive result doesn’t define your future – it empowers you to take control of your health journey.
Affordable Genetic Testing with Exceptional Value
| Test Feature | Details | Value |
|---|---|---|
| Regular Price | Comprehensive KCTD7 analysis | ZAR 9,350 |
| Special Price | Same comprehensive analysis | ZAR 6,700 |
| Turnaround Time | Results in 3-4 weeks | Included |
| Genetic Counselling | Pre-test session included | Included |
| Sample Collection | Blood or DNA sample options | Included |
Consider the cost savings compared to multiple specialist consultations and uncertain diagnostic journeys.
Why Trust Oracle Genomics?
We understand that genetic testing involves more than just science – it’s about people, families, and futures. Our commitment to you includes:
- Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Tests supervised by qualified neurologists and genetic specialists
- Accuracy Guarantee: Advanced NGS technology ensures 99.9% detection accuracy
- Patient Privacy: Strict confidentiality and ethical handling of your genetic information
- Compassionate Care: Our team understands the emotional journey of genetic testing
Take the First Step Toward Clarity Today
Don’t let uncertainty about your neurological symptoms control your life. Our KCTD7 genetic test provides the answers you need to move forward with confidence.
Limited Time Offer: Save ZAR 2,650 on your genetic testing while this special pricing lasts. Early detection can make a significant difference in managing Progressive Myoclonus Epilepsy symptoms.
Every day without answers is another day of uncertainty. Take control of your health journey today with definitive genetic testing from Oracle Genomics.
